LLY
753.95
+2.28%↑
JNJ
151.07
+1.12%↑
UNH
291.93
+7.04%↑
ABBV
183.3
+0.85%↑
NVO
64.06
-2.9%↓
LLY
753.95
+2.28%↑
JNJ
151.07
+1.12%↑
UNH
291.93
+7.04%↑
ABBV
183.3
+0.85%↑
NVO
64.06
-2.9%↓
LLY
753.95
+2.28%↑
JNJ
151.07
+1.12%↑
UNH
291.93
+7.04%↑
ABBV
183.3
+0.85%↑
NVO
64.06
-2.9%↓
LLY
753.95
+2.28%↑
JNJ
151.07
+1.12%↑
UNH
291.93
+7.04%↑
ABBV
183.3
+0.85%↑
NVO
64.06
-2.9%↓
LLY
753.95
+2.28%↑
JNJ
151.07
+1.12%↑
UNH
291.93
+7.04%↑
ABBV
183.3
+0.85%↑
NVO
64.06
-2.9%↓
24h
Current
Min
8.45
Max
8.91
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +85.19% upside |
Next Earnings | 11 sie 2025 |
---|
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
27 lis 2024, 13:34 UTC
CervoMed Shares Rise 15% on FDA's Orphan Drug Designation for Neflamapimod
DJ
Read
Price change
By TipRanks
12 Months Forecast
Average 16 USD 85.19%
High 21 USD
Low 10 USD
Based on 6 Wall Street analysts offering 12 month price targets forCervoMed Inc - Dist in the last 3 months.
By TipRanks
Strong Buy
6 ratings
6
Buy
0
Hold
0
Sell
Based on 6 analysts giving stock ratings to CervoMed Inc - Dist in the past 3 months.
$